SLFN11 and lung carcinoma: Several preclinical studies provided evidence for the role of SLFN11 in cytotoxic effects of PARPi and chemotherapy in for instance Ewing sarcoma and lung cancer (Iwasaki et al. 2019; Lok et al. 2017; Tang et al. 2015).